Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)

NCT02679144 is registered in ClinicalTrials.gov with Giselle Sholler as lead sponsor.

NCT NCT02679144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02679144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)
Lead sponsor
Giselle Sholler
Phase
Phase 2
Overall status
Active, not recruiting
Start date
February 29, 2016
Completion date
February 28, 2033
Enrollment
441 (estimated)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

neuroblastoma